3SBio Inc.
3SBio Inc. (HKSE: 1530) is trading at HK$15.92, about ₹195 at today's HKD/INR rate, as of 29 Sep 2026, 4:08 AM ET, up 1.92% today. Indian residents can buy 3SBio from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$15.61
Today's high
HK$16.35
52 week low
HK$14.81
52 week high
HK$35.42
1530 opened at HK$15.90, closed previously at HK$15.62, and has traded between HK$14.81 and HK$35.42 over the past 52 weeks.
About
Operating as an investment holding company, 3SBio Inc. specializes in the full lifecycle of biopharmaceutical products within the People's Republic of China, encompassing research, development, manufacturing, marketing, and sales. Its diverse portfolio addresses a range of medical needs. Key therapeutic agents include TPIAO, a recombinant human thrombopoietin for chemotherapy-induced and immune thrombocytopenia; YISAIPU, a tumor necrosis factor for rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and recombinant human erythropoietins EPIAO and SEPO, along with Aiyishu, to combat various forms of anemia. In oncology, Cipterbin is used for HER2-positive metastatic breast cancer in combination with chemotherapy. Intefen, a recombinant human interferon, targets lymphatic or hematopoietic malignancies and viral infections, while Inleusin, a human interleukin-2, treats renal cell carcinoma, melanoma, and thoracic fluid build-up. The company also offers Mandi for male alopecia and alopecia areata; Xenopax to prevent acute rejection post-renal transplant; Byetta for glycemic control in type 2 diabetes patients; and Qiming Keli for retinopathy linked to type 2 diabetes. SPARIN, an injectable low-molecular-weight heparin calcium, serves in the prophylaxis and treatment of deep vein thrombosis, and prevents clotting during hemodialysis. Beyond its core pharmaceutical activities, 3SBio Inc. provides additional services such as trading, project management and consultation, technology, and agricultural support. The company maintains strategic alliances with numerous prominent organizations, including AstraZeneca, Lilly, Toray Industries Inc, Samsung Bioepis, Refuge Biotechnologies, Verseau, TLC, Numab, GenSight, Sensorion, and the Dana–Farber Cancer Institute. Established in 1993, its headquarters are situated in Shenyang, People's Republic of China.
Key statistics
Avg. volume
29.93M
Market cap
HK$39.81B
P/E Ratio
4.09
Price-to-sales ratio
1.91
Enterprise value
CN¥43.85B
Free cash flow yield
17.05%
Debt-to-equity ratio
0.02
Return on equity
31.16%
ROIC
26.48%
Beta
0.45
Dividend yield
1.57%
Last dividend
HK$0.25
Financial overview
Revenue
CN¥17.70B
Earnings per share
CN¥3.43
Free cash flow
CN¥9.13B
Net profit margin
46.37%
Gross margin
91.97%
EBITDA
CN¥11.00B
Revenue growth
94.29%
Similar securities
This is not an investment recommendation
How to buy 3SBio from India
Indian residents can buy 3SBio shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for 3SBio and place an order
Find 3SBio by name or by its ticker, 1530, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. 3SBio trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your 3SBio position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in 3SBio from India
Trading and taxes when buying 3SBio from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. 3SBio’s current yield is 1.57%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy 3SBio stock?
Yes. 3SBio (1530) has been listed on the Hong Kong Stock Exchange since 2015, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one 3SBio share cost in rupees?
One 3SBio share is HK$15.92 — about ₹195 at an HKD/INR rate of 12.25 on 28 Sep 2026. Both the 3SBio price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying 3SBio from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of 3SBio?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on 3SBio shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the 3SBio price. Paasa issues a capital-gains statement for your return.
Does 3SBio pay a dividend, and how is it taxed in India?
Yes. 3SBio pays a dividend and the current yield is 1.57%; the last declared dividend was HK$0.25 per share, about ₹3.06. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade 3SBio from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is 3SBio a Hong Kong SAR China company, and does that change how it is taxed?
3SBio trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. 3SBio trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare 3SBio shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your 3SBio holding, its cost and its closing value.
How do I sell 3SBio and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.